AZN logo

AstraZeneca PLC (AZN)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus,...

NYSEHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
AZN
ISIN Code
US0463531089
Currency
US Dollar (USD)
IPO Date
1993-05-17

Contact Information

Company Address
1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
Contact Phone
44 20 3749 5000
Company Website
https://www.astrazeneca.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
1.90%
Return on Assets (TTM)
8.49%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99